Literature DB >> 3997184

Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system.

D R Vera, K A Krohn, P O Scheibe, R C Stadalnik.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3997184     DOI： 10.1109/TBME.1985.325544

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN： 0018-9294            Impact factor:   4.538


× No keyword cloud information.
  7 in total

1.  Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass.

Authors:  M Kudo; A Todo; K Ikekubo; M Hino; Y Yonekura; K Yamamoto; K Torizuka
Journal:  Gastroenterol Jpn       Date:  1991-12

2.  Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin.

Authors:  Y Yumoto; M Umeda; K Ohshima; H Ogawa; T Kurokawa; M Kajitani; E Yumoto; T Hanafusa; H Tsuboi; T Higashi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention.

Authors:  Kazuhiro Saito; Joseph Ledsam; Steven Sourbron; Tsuyoshi Hashimoto; Yoichi Araki; Soichi Akata; Koichi Tokuuye
Journal:  Eur Radiol       Date:  2013-08-15       Impact factor: 5.315

Review 4.  Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation.

Authors:  Kenneth A Krohn; David R Vera
Journal:  Nucl Med Biol       Date:  2020-03-12       Impact factor: 2.408

5.  Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.

Authors:  I Virgolini; C Müller; W Klepetko; P Angelberger; H Bergmann; J O'Grady; H Sinzinger
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

6.  Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.

Authors:  I Virgolini; G Kornek; J Höbart; S R Li; M Raolerer; H Bergmann; W Scheithauer; T Pantev; P Angelberger; H Sinzinger
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

7.  Potential application of neogalactosylalbumin in positron emission tomography evaluation of liver function.

Authors:  Shun-Da Du; Shao-Hua Li; Bao Jin; Zhao-Hui Zhu; Yong-Hong Dang; Hai-Qun Xing; Fang Li; Xue-Bing Wang; Xin Lu; Xin-Ting Sang; Hua-Yu Yang; Shou-Xian Zhong; Yi-Lei Mao
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.